Preventing or treating metastasis remains a significant challenge in clinical oncology. Current strategies focus on targeting the molecular pathways involved in metastasis, inhibiting ECM degradation, and blocking angiogenesis. Immunotherapy, which aims to harness the body's immune system to target and eliminate cancer cells, has also shown promise. Early detection and intervention are critical, as they can significantly improve prognosis and survival rates.
